Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, San Diego, California 92093, United States ...
Four years ago, protein drug developer Zymogenetics in Seattle began developing a recombinant version of the blood-clotting protein thrombin. On 17 January, it received US marketing approval for ...
Check out the nestjs-project-performance repository for examples using this alternative.
A model showing how metallic bonds are formed - the first diagram shows the outer electrons in their atoms, and the second diagram shows that the electrons have become delocalised ...
Furthermore, using nanocarriers to package high-procoagulant factors, such as thrombin, collagen and ... vasculatures are characterized by abnormal structure, sluggish blood flow, increased ...
Background: Cardiovascular disease(CVD) remains a significant global challenge. Asthma, which is characterized by airway hyperresponsiveness and reversible and limited airflow, plays an important role ...
The author(s) verify and take full responsibility for the use of generative AI in the preparation of this manuscript. Generative AI was used. The authors acknowledge the Chat Generative Pre-trained ...
was used Reduction of detection time to 2 h [68] CdTe QDs conjugated to oligonucleotides (molecular beacon structure) Simultaneous detection of single-base mutations in synthetic DNA targets using ...
1 Department of Cardiology, Cardiovascular Research Centre, Aalborg University Hospital, Aalborg, Denmark 2 Centre for Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, UK ...
Vascular Biology Program, Boston Children’s Hospital, MA (J.E.I., C.P., R.H.B.). Department of Surgery, Harvard Medical School, Boston, MA (J.E.I., C.P., R.H.B ...
5 Department of Cell Biology, New York University School of Medicine, New York, New York, USA Correspondence to Professor Xiu-Ping Yu, Institute of Pathogenic Biology, Shandong University School of ...